ALVO – alvotech - ordinary shares (US:NASDAQ)

News

Alvotech (ALVO) was upgraded by Wall Street Zen from "sell" to "hold"
Alvotech (ALVO) was downgraded by Wall Street Zen from "hold" to "sel
Alvotech (ALVO) Revenue Surges 21% Year-Over-Year in 2025 [Yahoo! Finance]
Teva receives FDA approval for Prolia biosimilar [Yahoo! Finance]
Alvotech Files Annual Report with the SEC
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com